Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
24 October 2016 |
Main ID: |
NCT02934100 |
Date of registration:
|
11/10/2016 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Evaluation of Effectiveness of Selected Physical and Kinesiotherapeutic Methods in Patients With Lower Calcaneal Spur
|
Scientific title:
|
Evaluation of Effectiveness of Selected Physical and Kinesiotherapeutic Methods in Patients With Lower Calcaneal Spur |
Date of first enrolment:
|
August 2016 |
Target sample size:
|
120 |
Recruitment status: |
Recruiting |
URL:
|
https://clinicaltrials.gov/show/NCT02934100 |
Study type:
|
Interventional |
Study design:
|
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment
|
Phase:
|
N/A
|
|
Countries of recruitment
|
Poland
| | | | | | | |
Contacts
|
Name:
|
Natalia Kociuga, master |
Address:
|
|
Telephone:
|
+48609018609 |
Email:
|
nkociuga@gmail.com |
Affiliation:
|
|
|
Name:
|
Natalia Kociuga, master |
Address:
|
|
Telephone:
|
+48609018609 |
Email:
|
nkociuga@gmail.com |
Affiliation:
|
|
|
Name:
|
Natalia Kociuga, master |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Medical University of Lodz, Poland |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- heel spur (calcaneal spur) diagnosed by a doctor based on X-ray examination,
diagnostic ultrasonography or MR
- signed informed consent
- heel pain for at least one month
Exclusion Criteria:
- pregnancy
- generalized acute infection (fever, cough, runny nose)
- local infection in the treated leg (wound, swelling)
- cancer
- injections of corticosteroids in the last six weeks
- pacemaker
- acute inflammation of the joints of the lower limbs
- inflammation of the veins
- Fresh fractures, post-traumatic
- osteoporosis
- Reynaud's disease
- Burger disease
- atherosclerosis
- after surgery condition before removing stitches
- High blood pressure
- after CT with contrast condition in the last two weeks
- The state of the lumbar puncture
- Strong imbalance
- Condition after myocardial infarction in the last six weeks
- Rheumatoid arthritis
- Ankylosing spondylitis
- Significant leg ulcers
- diabetes
- The risk of bleeding in the muscle tissue
- Thromboangiitis
- Hypersensitivity skin in the treated section
- A tendency to hemorrhage
- Pathological arrogance bone under the skin in the treated section
- Metal implants and surgical implants in the area of the lower limb subjected to
therapy
Age minimum:
40 Years
Age maximum:
75 Years
Gender:
Both
|
Health Condition(s) or Problem(s) studied
|
Heel Spur
|
Calcaneal Spur
|
Intervention(s)
|
Device: Sham LASER CTL1106MX
|
Device: Shock Master 300
|
Device: EVO US13 CosmoGamma
|
Device: Skanlab 25 BODYWAVE
|
Primary Outcome(s)
|
The Laitinen Pain Indicator Questionnaire
[Time Frame: Change from before the treatment and right after the treatment. Also change from after the treatment at 2 months.]
|
The SF-36v2 Health Survey (SF-36v2) - Change
[Time Frame: Change from before the treatment and right after the treatment. Also change from after the treatment at 2 months.]
|
The American Orthopedic Foot and Ankle Society Score (AOFAS) - Change
[Time Frame: Change from before the treatment and right after the treatment. Also change from after the treatment at 2 months.]
|
Secondary Outcome(s)
|
Heel standing test
[Time Frame: Patients will be screened using this scale three times: before treatment, immediately after its completion and two months after the end of therapy.]
|
Two weights test
[Time Frame: Patients will be screened using this scale three times: before treatment, immediately after its completion and two months after the end of therapy.]
|
The Visual Analogue Scale
[Time Frame: Patients will be screened using this scale three times: before treatment, immediately after its completion and two months after the end of therapy.]
|
Secondary ID(s)
|
RNN/47/16/KE
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|